Study Shows Apixaban Lowers Risk of Stroke in Patients with Subclinical Atrial Fibrillation

In a recent study published in the field of Cardiology, it has been found that apixaban, a type of oral anticoagulant, significantly lowers the risk of stroke or systemic embolism in patients with subclinical atrial fibrillation. This finding is significant…